FDA-Inspected Site

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy

2 FDA inspections are on record for Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy in Bristol, United States.

Clean· No action indicated

Bristol, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2021-09-09.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
30 Aug 2021 – 9 Sep 2021Human DrugsClean
26 Mar 2019 – 5 Apr 2019Human DrugsWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

5 Apr 2019
FDCA 501(a)(2)(A)

Ceiling tiles, cleanroom

Cited by Xiaohui Shen, June P Page

5 Apr 2019
FDCA 501(a)(2)(A)

Cleanliness, ISO-classified areas

Cited by Xiaohui Shen, June P Page

5 Apr 2019
FDCA 501(a)(2)(A)

Hazardous drugs, prevention of cross-contamination

Cited by Xiaohui Shen, June P Page

5 Apr 2019
FDCA 501(a)(2)(A)

Non-microbial contamination, production area

Cited by Xiaohui Shen, June P Page

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations4x

Full site report

Get the verbatim findings behind this site's 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat